Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy-Reference-Cited by-同舟云学术

Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy

Published:2017-02-03 Issue:2 Volume:21 Page:187-198
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Hanaoka Tatsuya,Hasegawa Kosei,Kato Tomomi,Sato Sho,Kurosaki Akira,Miyara Akiko,Nagao Shoji,Seki Hiroyuki,Yasuda Masanori,Fujiwara Keiichi

Funder

Ochiai Memorial Award

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-017-0255-2.pdf

Reference48 articles.

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi: 10.3322/caac.21166 .

2. Gonzalez-Diego P, Lopez-Abente G, Pollan M, Ruiz M. Time trends in ovarian cancer mortality in Europe (1955–1993): effect of age, birth cohort and period of death. Eur J Cancer (Oxford, England: 1990). 2000;36(14):1816–24.

3. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334(1):1–6. doi: 10.1056/NEJM199601043340101 .

4. Ledermann JA, Kristeleit RS. Optimal treatment for relapsing ovarian cancer. Ann Oncol. 2010;21(Suppl 7):vii218–22. doi: 10.1093/annonc/mdq377 .

5. Schwab CL, English DP, Roque DM, Pasternak M, Santin AD. Past, present and future targets for immunotherapy in ovarian cancer. Immunotherapy. 2014;6(12):1279–93. doi: 10.2217/imt.14.90 .

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy;Journal of Ovarian Research;2024-08-08

2. Mesothelin-targeted MRI for assessing migration, invasion, and prognosis in malignant pleural mesothelioma;Cancer Nanotechnology;2024-01-05

3. A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal Adenocarcinoma;Annals of Surgery;2023-04-27

4. Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion;Medicine;2023-01-27

5. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer;Applied Immunohistochemistry & Molecular Morphology;2023-01-09